ImpediMed Limited is the world leader in the development and distribution of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status. ImpediMed’s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm and leg in female and male cancer patients.
Company Details
- Employees
- 102
- Founded
- -
- Address
- 5900 Pasteur Ct. Suite 125, Carlsbad,ca 92008,united States
- Phone
- + 61 7 3860 3700
- en****@****med.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- impedimed.com
- HQ
- Carlsbad, CA
Impedimed Questions
Impedimed's helpline number is + 61 7 3860 3700
Impedimed's website is impedimed.com
Impedimed's LinkedIn profile is https://www.linkedin.com/company/impedimed
Impedimed has
102 employees.
View email and phone details for 102
employees at Impedimed.
Impedimed's industry is
Medical Equipment Manufacturing
Impedimed's top competitors are
Medtronic,
Levee Medical, Inc.,
Renovorx (Nasdaq: Rnxt),
Newronika S.p.a.,
Nurture Growth Fund,
Teclens,
Prenuvo,
Scibase,
Pfizer,
Hologic, Inc..
Impedimed's support email address is enquiries@impedimed.com
Impedimed's categories are Medical Equipment Manufacturing
Impedimed's founding year is 1999
